BMJ Open (Jun 2022)
RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy
- Janelle Yorke,
- Sarah O’Connell,
- Sally Taylor,
- Karen Johnson,
- Robert G Bristow,
- Martin Eden,
- Kate Haslett,
- John Moore,
- Rohit Kochhar,
- Victoria Chatzimavridou Grigoriadou,
- Lisa H Barraclough,
- Ivona Baricevic-Jones,
- Zoe Merchant,
- Thomas Westwood,
- Anthony David Whetton,
- Claire E Higham
Affiliations
- Janelle Yorke
- Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK
- Sarah O’Connell
- Infectious Disease, University Hospital Limerick, Dooradoyle, Ireland
- Sally Taylor
- Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK
- Karen Johnson
- Preventive Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee, USA
- Robert G Bristow
- Division of Cancer Sciences, Faculty of Biology, Health and Medicine, University of Manchester; Cancer Research UK Manchester Institute and Manchester Cancer Research Centre; The Christie NHS Foundation Trust, Manchester, UK
- Martin Eden
- Manchester Academic Health Sciences Centre, Health Innovation Manchester, Manchester, UK
- Kate Haslett
- 1Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
- John Moore
- 4Third Fleet, US Navy, San Diego, California, USA
- Rohit Kochhar
- Department of Radiology, The Christie NHS Foundation Trust, Manchester, UK
- Victoria Chatzimavridou Grigoriadou
- Department of Endocrinology, The Christie Hospital NHS Foundation Trust, Manchester, UK
- Lisa H Barraclough
- Department of Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK
- Ivona Baricevic-Jones
- Stoller Biomarker Discovery Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
- Zoe Merchant
- Greater Manchester ‘Prehab4Cancer and Recovery programme’/Highly Specialist Occupational Therapist, GM Cancer alliance hosted by the Christie NHS Foundation Trust, Manchester, UK
- Thomas Westwood
- Department of Radiology, The Christie NHS Foundation Trust, Manchester, UK
- Anthony David Whetton
- Stoller Biomarker Discovery Centre, The University of Manchester, Manchester, UK
- Claire E Higham
- Department of Endocrinology, The Christie Hospital NHS Foundation Trust, Manchester, UK
- DOI
- https://doi.org/10.1136/bmjopen-2021-056600
- Journal volume & issue
-
Vol. 12,
no. 6
Abstract
No abstracts available.